Tag

PMWS

Michael Kamarck & Pascal Bécotte — Global Talent Trends in Pharma and Biotech Technical Operations: A Perfect Storm
LIFE SCIENCES, VIDEO, LIFE SCIENCES, PODCAST

Michael Kamarck & Pascal Bécotte — Global Talent Trends in Pharma and Biotech Technical Operations: A Perfect Storm

At the most recent edition of the Pharma Manufacturing World Summit held May 15-16, 2023, in Boston, we spoke with Michael Kamarck, a senior industry executive, and Pascal Bécotte, the Managing Director of Russell Reynolds Associates, about the most serious challenge threatening to bottleneck the otherwise very bright future of medicine. For a number of reasons explored in both this interview and in this recent blog post, there are not enough qualified people to fill all the top jobs that need to be done, and this is not something that is going to be fixed in a day or even a few years without the industry working together in a decisive and unprecedented way to collectively develop its rising Top Talent in the technical operations space into the senior leaders that Small Molecule, Large Molecule, and especially the emerging Advanced Therapy Medicinal Products sectors cannot do without.

Continue reading
Cell and Gene Therapy Issues and Trends — A Conversation with Judith Koliwer, PhD, of Körber Pharma Software
LIFE SCIENCES, VIDEO, LIFE SCIENCES, PODCAST

Cell and Gene Therapy Issues and Trends — A Conversation with Judith Koliwer, PhD, of Körber Pharma Software

At the most recent edition of the Pharma Manufacturing World Summit held May 15-16, 2023, in Boston, we spoke with Judith Koliwer, PhD, the Principal Consultant Cell & Gene Therapy Software, Körber Business Area Pharma at Körber Pharma Software. Judith is one of the industry’s leading experts on Cell and Gene Therapies, as she led an academic research group on CGT processes years before these new therapies were approaching commercial manufacturing. At PMWS23 she gave a presentation entitled, “The Iterative Approach to a Digital Cell and Gene Therapy Process – an Overview & Best Practice.” In this interview we discuss what she shared with the audience, as well as her thoughts on current issues and trends pharmaceutical manufacturers need to be aware of as they forge a path into the new frontier of medicine. Give this one a listen!

Continue reading
Packaging and Supply Chain for the Pharmaceutical Industry — A Conversation with Hunter Malick of Sharp Packaging Services
LIFE SCIENCES, VIDEO, LIFE SCIENCES, PODCAST

Packaging and Supply Chain for the Pharmaceutical Industry — A Conversation with Hunter Malick of Sharp Packaging Services

At the most recent edition of the Pharma Manufacturing World Summit we sat down with Hunter Malick of Sharp Packaging Services to talk about how pharmaceutical manufacturers are working internally and externally to improve their capabilities and capacity when it comes to packaging, especially as it relates to changes and updates that could potentially bottleneck the industry’s supply chain. In a business landscape where the rate of innovation keeps accelerating, the product pipeline coming to market is full, and regulatory requirements are frequently adjusted in relation to packaging and labeling, it has never been more important to understand the options available to scale up packaging production and make quick adjustments as needed to make sure the flow of products to patients is not interrupted. Give this one a listen!

Continue reading
AI & the Pharmaceutical Industry (Many Companies Are Closer Than They Think!) — A Conversation with Andy Alasso of Aizon
LIFE SCIENCES, VIDEO, LIFE SCIENCES, PODCAST

AI & the Pharmaceutical Industry (Many Companies Are Closer Than They Think!) — A Conversation with Andy Alasso of Aizon

At the most recent edition of the Pharma Manufacturing World Summit we sat down with Andy Alasso, Aizon’s Chief Product and Customer Successor Officer, to talk about what Artificial Intelligence is going to do for Pharmaceutical Manufacturers now, in the near-future, and in the years to come. It may surprise many business leaders to learn they are closer to being ready to incorporate AI tools into their existing toolbox than they think. The very nature of pharmaceutical manufacturing, which is data-centric by nature, lends itself well to AI. What should industry leaders be thinking about and learning about when it comes to these powerful new tools? Give this episode a listen to find out!

Continue reading
Global Talent Trends in Pharma Manufacturing
LIFE SCIENCES, VIDEO, LIFE SCIENCES

Global Talent Trends in Pharma Manufacturing

Our knee-jerk leadership reaction to the pandemic: from managing change to managing burn-outs! Recovery: how to reboot culture, leading with purpose and agility Defining and adopting next-gen performance and talent management — Pascal Bécotte Managing Director Russell Reynolds Associates Pascal leads Canadian operations for Russell Reynolds Associates and is also a member of the firm’s global Executive Committee. He is a key member of the Healthcare Sector where he advises clients across the globe on their overall talent strategy, particularly with respect to leadership assessment, succession planning and the recruitment of directors, CEOs and other senior executives. More specifically Pascal…

Continue reading
Avoiding the Pitfalls of Initial GMP Programming and Clinical Production Space Planning
LIFE SCIENCES, VIDEO, LIFE SCIENCES

Avoiding the Pitfalls of Initial GMP Programming and Clinical Production Space Planning

Discussing the common pitfalls observed during establishment of initial GMP programs in the areas of quality systems, materials management, supplier qualification, etc. How are companies adopting organizational changes and leveraging digital systems to avoid these pitfalls? Important factors to consider when assessing build vs. buy for early-phase clinical production, and considerations for scaling a GMP program up and/or out Illustrating the importance of establishing clear process requirements and conducting informal and formal facility fit assessments using real-world examples — Chris Mansur President, Azzur Consulting Azzur Group Chris Mansur currently serves as the President of Azzur Group’s Consulting division, which specializes…

Continue reading
Advancing Pharmaceutical Manufacturing Quality
LIFE SCIENCES, VIDEO, LIFE SCIENCES

Advancing Pharmaceutical Manufacturing Quality

 Using innovative thinking to realize a future more “immune” to supply chain disruptions Incentivizing improvements to the pharmaceutical manufacturing infrastructure that enhance the reliability of manufacturing and supply Delivering on the promise of advanced manufacturing to provide reliable, available, high-quality drugs for patients — Michael Kopcha Director, Office of Pharmaceutical Quality, CDER FDA Michael Kopcha, Ph.D., R.Ph., Director, Office of Pharmaceutical Quality (OPQ), is a leader in the development of innovative solutions to resolve scientific, manufacturing, and commercialization issues worldwide – and in standardizing and harmonizing global processes. With more than 25 years of pharmaceutical industry experience, his areas of expertise…

Continue reading
Managing Innovation and Variability in a Growth Environment
LIFE SCIENCES, VIDEO, LIFE SCIENCES

Managing Innovation and Variability in a Growth Environment

How the pandemic impacted the structure and responsiveness of our global networks Responding to new geographic fluctuation of demand by disease states and patient delivery The challenges and opportunities posed by new product innovation and managing lifecycles — Linzell Harris SVP Global Supply Chain and Strategy AstraZeneca Linzell Harris is senior vice president of Global Supply Chain and Strategy for AstraZeneca, with overall responsibility for the development and execution of the end to end supply chain platform and product supply strategies. In addition, he is responsible for ensuring the strategic development of network designs and supply chain capabilities supporting the…

Continue reading
Creating and Maintaining a Resilient Supply Chain: Lessons Learned from a Pandemic
LIFE SCIENCES, VIDEO, LIFE SCIENCES

Creating and Maintaining a Resilient Supply Chain: Lessons Learned from a Pandemic

How do you define a supply chain? The what, the who, the where and the how Risk categorization Impact, probability and detectability Risk approach Detection, prevention/mitigation and response Near-miss lessons learned — Ken Kent SVP, Chemical Development and Manufacturing Operations Gilead Ken is the Senior Vice President of Chemical Development and Manufacturing Operations. He is responsible for Gilead’s entire drug substance supply and oversees process R&D functions in Foster City and Edmonton, as well as internal and outsourced manufacturing. He played a critical role leading CDMO in sourcing ingredients and scaling up production of remdesivir drug substance, to speed up…

Continue reading
Pharmaceutical Development and Manufacturing — The New Post-Pandemic Realities
LIFE SCIENCES, VIDEO, LIFE SCIENCES

Pharmaceutical Development and Manufacturing — The New Post-Pandemic Realities

Discussing how the business model change accelerates Highlighting transformation needs in business setup, technology and ways of working Impact on Development and Manufacturing of different modalities How does Bayer gets prepared for such opportunities and challenges? — Wolfram Carius EVP Pharmaceuticals Bayer AG Prof. Wolfram Carius is the EVP Pharmaceuticals at Bayer AG and is a member of the Executive Committee for Bayer Pharmaceuticals. He is based in Berlin, Germany. Prior to joining Bayer, Wolfram was a corporate senior vice president and member of the global leadership team at Sanofi Genzyme for nearly three years. Before that, he worked for…

Continue reading
Idea to Performance: The Impossible Journey
LIFE SCIENCES, VIDEO, LIFE SCIENCES

Idea to Performance: The Impossible Journey

Moderna pre-pandemic times: Sciences, Platform, and Company History Moderna’s preparation COVID-19. Operations insight for an unprecedented scale-up Execution against the plan. Overcoming challenges Moderna’s future operations — Juan Andres Chief Technical and Quality Officer Moderna As Chief Technical and Quality officer, Juan Andres is responsible for Technical Development, product supply at pre-clinical, clinical and commercial stages and quality across Moderna globally (i.e. CMC); chemistry, manufacturing and controls Mr. Andres was previously the Global Head of Technical Operations (Manufacturing and Supply Chain) for over 25,000 Novartis employees across all of its divisions. In this role, he had responsibility for all of…

Continue reading